Mixed results with baricitinib in biological-resistant adult-onset Still’s disease and undifferentiated systemic autoinflammatory disease

This clinical case series describes our experience with the use of Janus kinase 1/2 inhibitor baricitinib in two patients suffering from refractory adult-onset Still’s disease (AOSD) as well as in one case suffering from AOSD-like autoinflammatory disease in the context of myelodysplastic syndrome....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:RMD Open
Autors principals: Kacar, Mark, Fitton, John, Gough, Andrew K, Buch, Maya H, McGonagle, Dennis G, Savic, Sinisa
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Autoinflammatory Disorders
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7425191/
https://ncbi.nlm.nih.gov/pubmed/32669454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2020-001246
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars